Baird Financial Group Portfolio holdings
AUM
$57B
1-Year Return
20.87%
This Quarter Return
+1.53%
1 Year Return
+20.87%
3 Year Return
+74.96%
5 Year Return
+130.49%
10 Year Return
+303.64%
AUM
$48.2B
AUM Growth
+$517M
(+1.1%)
Cap. Flow
+$541M
Cap. Flow
% of AUM
1.12%
Top 10 Holdings %
Top 10 Hldgs %
23.88%
Holding
1,852
New
102
Increased
811
Reduced
727
Closed
99
Top Buys
| 1 |
GE Vernova
GEV
|
$243M |
| 2 |
CarMax
KMX
|
$72.9M |
| 3 |
Zebra Technologies
ZBRA
|
$55M |
| 4 |
Raymond James Financial
RJF
|
$53M |
| 5 |
Meta Platforms (Facebook)
META
|
$51.7M |
Top Sells
| 1 |
Pfizer
PFE
|
$93M |
| 2 |
RBC Bearings
RBC
|
$83.2M |
| 3 |
GE Aerospace
GE
|
$60.7M |
| 4 |
Align Technology
ALGN
|
$59.3M |
| 5 |
HEICO
HEI
|
$53.9M |
Sector Composition
| 1 | Technology | 20.05% |
| 2 | Financials | 12.75% |
| 3 | Industrials | 10.15% |
| 4 | Consumer Discretionary | 8.15% |
| 5 | Healthcare | 8.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Invesco Municipal Income Opportunities Trust
OIA
$283M
| $79.7K | ﹤0.01% |
12,555
-40,379
| -76% | -$256K |
|
1727
QuantumScape
QS
$4.44B
| $78.9K | ﹤0.01% |
16,035
-2,300
| -13% | -$11.3K |
|
1728
SiriusXM
SIRI
$8.1B
| $77.2K | ﹤0.01% |
2,728
-113
| -4% | -$3.2K |
|
1729
Lucid Motors
LCID
$5.66B
| $73.4K | ﹤0.01% |
2,813
-1,580
| -36% | -$41.2K |
|
|
BLUE
1730
DELISTED
bluebird bio
BLUE
| $61.3K | ﹤0.01% |
3,113
+2,488
| +398% | +$49K |
|
1731
Catheter Precision
VTAK
$3.03M
| $58.8K | ﹤0.01% |
529
| – | – |
|
1732
Kosmos Energy
KOS
$784M
| $55.4K | ﹤0.01% |
+10,000
| New | +$55.4K |
|
1733
OmniAb
OABI
$246M
| $54.7K | ﹤0.01% |
14,580
-170
| -1% | -$638 |
|
1734
OPAL Fuels
OPAL
$65.5M
| $54.2K | ﹤0.01% |
13,249
| – | – |
|
1735
Geron
GERN
$893M
| $48.8K | ﹤0.01% |
+11,500
| New | +$48.8K |
|
1736
ChargePoint
CHPT
$239M
| $42.3K | ﹤0.01% |
1,401
-168
| -11% | -$5.08K |
|
1737
Leap Therapeutics
LPTX
$11.7M
| $41.9K | ﹤0.01% |
+21,400
| New | +$41.9K |
|
1738
Nordic American Tanker
NAT
$692M
| $39.8K | ﹤0.01% |
+10,000
| New | +$39.8K |
|
1739
Cognition Therapeutics
CGTX
$230M
| $37.2K | ﹤0.01% |
22,393
| – | – |
|
1740
B2Gold
BTG
$5.52B
| $33.8K | ﹤0.01% |
12,500
-12,300
| -50% | -$33.2K |
|
1741
Karyopharm Therapeutics
KPTI
$57.2M
| $31.9K | ﹤0.01% |
2,453
+1,066
| +77% | +$13.9K |
|
1742
Lumen
LUMN
$4.87B
| $30.6K | ﹤0.01% |
27,786
-13,126
| -32% | -$14.4K |
|
|
CLLS
1743
Cellectis
CLLS
$269M
| $28.2K | ﹤0.01% |
+15,090
| New | +$28.2K |
|
1744
Globalstar
GSAT
$3.96B
| $28K | ﹤0.01% |
1,667
| – | – |
|
1745
Wallbox
WBX
$67.2M
| $25.8K | ﹤0.01% |
986
-14
| -1% | -$367 |
|
|
NGD
1746
New Gold Inc
NGD
$4.99B
| $22.4K | ﹤0.01% |
11,500
| – | – |
|
1747
Cerus
CERS
$255M
| $21K | ﹤0.01% |
11,950
| – | – |
|
|
FLDDW
1748
Fold Holdings, Inc. Warrant
FLDDW
$5.12M
| $18K | ﹤0.01% |
400,994
| – | – |
|
1749
Akebia Therapeutics
AKBA
$785M
| $17.7K | ﹤0.01% |
17,393
+1,650
| +10% | +$1.68K |
|
|
TELL
1750
DELISTED
Tellurian Inc.
TELL
| $13.7K | ﹤0.01% |
19,762
| – | – |
|